Here are some of the latest health and medical news
developments, compiled by the editors of HealthDay:
Study of Daily Anti-HIV Pill Halted
A study of a daily pill to prevent HIV infection has been halted
because partial results show that the drug offers no benefit to
women using it, researchers say.
The findings from the clinical trial involving thousands of
African women show that those taking the drug Truvada are just as
likely to get HIV as women taking a placebo pill, the
Associated Press reported.
The decision to halt the trial was announced Monday by Family
Health International, a nonprofit group that launched the study two
years ago. While no safety problems were seen with Truvada, women
taking the pill were more likely to become pregnant than those
taking the placebo.
"That's both a surprising finding and one that we can't readily explain" by what's currently known about the drug's effects on women using hormonal contraceptives, said Dr. Timothy Mastro of Family Health International, the AP reported.
A study released last fall found that Truvada did help prevent
HIV infection in gay and bisexual men when used with prevention
services such as condoms, counseling.
The leader of that study said it's difficult to understand why
the drug didn't protect women against HIV infection. Blood samples
may explain whether that failure is related to how faithfully women
in the study took the drug, Dr. Robert M. Grant told the
Truvada, made by California-based Gilead Sciences Inc., is a
combination of two drugs, tenofovir and emtricitabine. It is
already sold for treating HIV infection, the
Supreme Court Silent on Health Care Law Case
The U.S. Supreme Court made no mention Monday of a case
involving Virginia's request for a swift review of the national
health care law.
The case was among those scheduled for discussion during the
justices' private conference Friday, but there was no notice about
the case when the court convened Monday, the
Associated Press reported.
There could be a number of reasons for this silence, such as a
justice asking for more time to consider the case or to write a
short opinion that would accompany an order.
Pending cases will be discussed again Friday.
Remarks Deemed Offensive Cause Head of Surgeons Group to
After weeks of controversy over an editorial that outraged many
women in the medical field, the president-elect of the American
College of Surgeons resigned his position Sunday.
Dr. Lazar Greenfield was editor in chief of
Surgery News when he wrote a Valentine's Day editorial that
touted the mood-enhancing effects of semen on women during
The New York Times reported.
His editorial referred to a study that suggested compounds in
semen may have antidepressant effects on women. "So there's a
deeper bond between men and women than St. Valentine would have
suspected, and now we know there's a better gift for that day than
chocolates," Greenfield concluded in the editorial.
Many women in the medical field were angered by the editorial,
saying it reflected a macho culture in surgery. As a result, the
entire issue of
Surgery News was withdrawn and Greenfield resigned as editor
But the controversy continued to follow him and Greenfield said
he decided to resign as president-elect of the American College of
Surgeons "rather than have this remain a disruptive issue," he said
in a statement sent by e-mail,
The Times reported.
Greenfiled is an emeritus professor of surgery at the University
of Michigan School of Medicine.
New Anti-Fatigue Rules for Air Traffic Controllers
Longer breaks between shifts for air traffic controllers are
among the new anti-fatigue rules announced by the U.S. Federal
Aviation Administration following a series of incidents in which
air traffic controllers fell asleep on the job.
Air traffic controllers will now have at least nine hours off
between shifts instead of the current eight-hour minimum, under the
new rules. In addition, controllers will not be allowed to switch
shifts with another controller unless they have had at least nine
hours off, and FAA managers will be working more late-night and
early-morning shifts to better monitor controllers,
USA Today reported.
But allowing controllers to have naps during a shift doesn't
appear to be under consideration, even though some experts believe
it's a good idea.
"On my watch, controllers will not be paid to take naps," Transportation Secretary Ray LaHood said on Fox News Sunday, according to
USA Today. "We want to make sure they're well rested. We want to make (sure) that in the workplace there's the ability for them to do their job, but we're not going to pay controllers to be napping. We're not going to do that."
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.